相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis: a clinical pharmacological perspective on a surgical procedure
Loek A. W. de Jong et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer
Carolina Moretto Carnielli et al.
NATURE COMMUNICATIONS (2018)
Pharmacokinetic interaction between taxanes and amiodarone leading to severe toxicity
Felix Hammann et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Circadian Clock Gene Bmal1 Inhibits Tumorigenesis and Increases Paclitaxel Sensitivity in Tongue Squamous Cell Carcinoma
Qingming Tang et al.
CANCER RESEARCH (2017)
Transcriptional architecture of the mammalian circadian clock
Joseph S. Takahashi
NATURE REVIEWS GENETICS (2017)
Rhythmic expressed clock regulates the transcription of proliferating cellular nuclear antigen in teleost retina
Hang Song et al.
EXPERIMENTAL EYE RESEARCH (2017)
MALAT1 Is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2
Peilong Li et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Forging Ahead through Darkness: PCNA, Still the Principal Conductor at the Replication Fork
Katherine N. Choe et al.
MOLECULAR CELL (2017)
An assay to detect DNA-damaging agents that induce nucleotide excision-repairable DNA lesions in living human cells
Reine Takatsuka et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2017)
Synergistic antitumor effects of the combined treatment with an HDAC6 inhibitor and a COX-2 inhibitor through activation of PTEN
Guanhua Zhang et al.
ONCOLOGY REPORTS (2017)
Systems Chronotherapeutics
Annabelle Ballesta et al.
PHARMACOLOGICAL REVIEWS (2017)
The Circadian Clock Gene Bmal1 Controls Thyroid Hormone-Mediated Spectral Identity and Cone Photoreceptor Function
Onkar B. Sawant et al.
CELL REPORTS (2017)
Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis
Nicole M. Kettner et al.
CANCER CELL (2016)
Per2 induction limits lymphoid-biased haematopoietic stem cells and lymphopoiesis in the context of DNA damage and ageing
Jianwei Wang et al.
NATURE CELL BIOLOGY (2016)
Mammalian Period represses and de-represses transcription by displacing CLOCK-BMAL1 from promoters in a Cryptochrome-dependent manner
Yi-Ying Chiou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Circadian physiology of metabolism
Satchidananda Panda
SCIENCE (2016)
Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin
Yanqing Liu et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Dosing-Time Makes the Poison: Circadian Regulation and Pharmacotherapy
Robert Dallmann et al.
TRENDS IN MOLECULAR MEDICINE (2016)
PFKFB3 Control of Cancer Growth by Responding to Circadian Clock Outputs
Lili Chen et al.
SCIENTIFIC REPORTS (2016)
The Adenovirus E4orf4 Protein Provides a Novel Mechanism for Inhibition of the DNA Damage Response
Anna Brestovitsky et al.
PLOS PATHOGENS (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance
Eva Martinez-Balibrea et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Nucleotide excision repair efficiency in quiescent human fibroblasts is modulated by circadian clock
Leonardo Bee et al.
NUCLEIC ACIDS RESEARCH (2015)
Circadian and Melatonin Disruption by Exposure to Light at Night Drives Intrinsic Resistance to Tamoxifen Therapy in Breast Cancer
Robert T. Dauchy et al.
CANCER RESEARCH (2014)
Thoracic surface temperature rhythms as circadian biomarkers for cancer chronotherapy
Veronique Pasquale Roche et al.
CHRONOBIOLOGY INTERNATIONAL (2014)
Overexpression of the Circadian Clock Gene Bmal1 Increases Sensitivity to Oxaliplatin in Colorectal Cancer
Zhao-lei Zeng et al.
CLINICAL CANCER RESEARCH (2014)
A Small Molecule Inhibitor of Monoubiquitinated Proliferating Cell Nuclear Antigen (PCNA) Inhibits Repair of Interstrand DNA Cross-link, Enhances DNA Double Strand Break, and Sensitizes Cancer Cells to Cisplatin
Akira Inoue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Modulation of ATR-mediated DNA damage checkpoint response by cryptochrome 1
Tae-Hong Kang et al.
NUCLEIC ACIDS RESEARCH (2014)
PCNA: a silent housekeeper or a potential therapeutic target?
Shao-Chun Wang
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2)
Frank Buttgereit et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
The circadian clock and cell cycle: interconnected biological circuits
Selma Masri et al.
CURRENT OPINION IN CELL BIOLOGY (2013)
Regulation of PCNA-protein interactions for genome stability
Niels Mailand et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
Sex moderates circadian chemotherapy effects on survival of patients with metastatic colorectal cancer: a meta-analysis
S. Giacchetti et al.
ANNALS OF ONCOLOGY (2012)
Cell-autonomous circadian DNA damage response: Is the case closed?
Roman V. Kondratov
CELL CYCLE (2012)
Brain and muscle Arnt-like protein-1 (BMAL1) controls circadian cell proliferation and susceptibility to UVB-induced DNA damage in the epidermis
Mikhail Geyfman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Recurrent oral cancer: current and emerging therapeutic approaches
Sabrina Daniela da Silva et al.
FRONTIERS IN PHARMACOLOGY (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Role of Endonucleases XPF and XPG in Nucleotide Excision Repair of Platinated DNA and Cisplatin/Oxaliplatin Cytotoxicity
Nora Graf et al.
CHEMBIOCHEM (2011)
Role of Circadian Clocks in the Development and Therapeutics of Cancer
X-L Huang et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2011)
Control of skin cancer by the circadian rhythm
Shobhan Gaddameedhi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Circadian Timing in Cancer Treatments
Francis Levi et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
Identification of cisplatin-resistance related genes in head and neck squamous cell carcinoma
Yukio Yamano et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Eukaryotic Translesion Polymerases and Their Roles and Regulation in DNA Damage Tolerance
Lauren S. Waters et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2009)
Harmonics of Circadian Gene Transcription in Mammals
Michael E. Hughes et al.
PLOS GENETICS (2009)
Induction of cancer metastasis by cyclophosphamide pretreatment of host mice: An opposite effect of chemotherapy
Kensuke Yamauchi et al.
CANCER RESEARCH (2008)
Glucocorticoid chronotherapy in rheumatoid arthritis
Johannes W. J. Bijlsma et al.
LANCET (2008)
Implications of circadian clocks for the rhythmic delivery of cancer therapeutics
Francis Levi et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES (2008)
Implications of circadian clocks for the rhythmic delivery of cancer therapeutics
Francis Levi et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Targeting DNA repair as a promising approach in cancer therapy
Giovanna Damia et al.
EUROPEAN JOURNAL OF CANCER (2007)
Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer:: The European Organisation for Research and Treatment of Cancer Chronotherapy group
Sylvie Giacchetti et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Oxaliplatin, folinic acid and 5-fluorouracil (OFF) in patients with recurrent advanced head and neck cancer: A phase II feasibility study
Jan Dirk Raguse et al.
ORAL ONCOLOGY (2006)
The circadian PAR-domain basic leucine zipper transcription factors DBP, TEF, and HLF modulate basal and inducible xenobiotic detoxification
Federic Gachon et al.
CELL METABOLISM (2006)
A role for polymerase η in the cellular tolerance to cisplatin-induced damage
MR Albertella et al.
CANCER RESEARCH (2005)
Expression of class III β-tubulin is predictive of patient outcome in patients with non-small cell lung cancer receiving vinorelbine-based chemotherapy
P Sève et al.
CLINICAL CANCER RESEARCH (2005)
Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan
J Boyer et al.
CLINICAL CANCER RESEARCH (2004)
Coordination of circadian timing in mammals
SM Reppert et al.
NATURE (2002)
Interacting molecular loops in the mammalian circadian clock
LP Shearman et al.
SCIENCE (2000)
Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma:: three meta-analyses of updated individual data
JP Pignon et al.
LANCET (2000)
分享论文
